A new study highlights how the beliefs of surgeons and radiation oncologists influences radiotherapy use in early-stage breast cancer among older women. Should older women with stage I estrogen ...
Dropping chemotherapy from a first-line regimen of trastuzumab (Herceptin) and pertuzumab (Perjeta) didn't compromise overall survival at 2 years in advanced HER2-positive breast cancer, although ...
Axillary lymph node dissection (ALND) is now commonly omitted in sentinel node (SN)-negative breast cancer patients. Although this approach avoids ALND-associated morbidity, its safety depends on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results